Jill E. Slansky
Affiliations: | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Immunology, Oncology, Cell BiologyGoogle:
"Jill Slansky"Children
Sign in to add traineeRachel H. McMahan | grad student | 2007 | University of Colorado, Denver |
Kimberly R. Jordan | grad student | 2009 | University of Colorado, Denver |
Charles B. Kemmler | grad student | 2011 | University of Colorado, Denver |
Jonathan D. Buhrman | grad student | 2012 | University of Colorado, Denver |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hay ZLZ, Knapp JR, Magallon RE, et al. (2023) Low TCR binding strength results in increased progenitor-like CD8+ tumor-infiltrating lymphocytes. Cancer Immunology Research |
Camp FA, Brunetti TM, Williams MM, et al. (2022) Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8 T Cell Immunity. Cancers. 14 |
Wang Y, Tsitsiklis A, Devoe S, et al. (2022) Peptide Centric Vβ Specific Germline Contacts Shape a Specialist T Cell Response. Frontiers in Immunology. 13: 847092 |
Hay ZLZ, Slansky JE. (2022) Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity. International Journal of Molecular Sciences. 23 |
Camp FA, Slansky JE. (2021) Implications of Antigen Selection on T Cell-Based Immunotherapy. Pharmaceuticals (Basel, Switzerland). 14 |
Wei P, Jordan KR, Buhrman JD, et al. (2021) Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer. Proceedings of the National Academy of Sciences of the United States of America. 118 |
Marín-Jiménez JA, Capasso A, Lewis MS, et al. (2021) Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes. Frontiers in Immunology. 12: 607282 |
Jordan K, Sikora MJ, Slansky JE, et al. (2020) The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free interval. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Katz SC, Moody AE, Guha P, et al. (2020) HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery. Journal For Immunotherapy of Cancer. 8 |
Hoffmann MM, Slansky JE. (2020) T-cell receptor affinity in the age of cancer immunotherapy. Molecular Carcinogenesis |